We would like to hear from those in the United States who have had challenges with insurance coverage of an FDA-approved medication indicated to treat EoE (eosinophilic esophagitis).
If you live in the U.S. and have been prescribed one of these medications to treat EoE, we’d be grateful if you answered a few questions to help us advocate for better coverage.